Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix Natural Daylight Photodynamic Therapy versus Metvix conventional Photodynamic Therapy in subjects with actinic keratosis [Estudio multicentrico, aleatorizado, enmascarado para el investigador, con control intraindividual con fármaco activo y con vehículo, de comparación entre el tratamiento fotodinámico Metvix con luz solar natural y el tratamiento fotodinamico Metvix convencional en pacientes con queratosis actínica]

Trial Profile

Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix Natural Daylight Photodynamic Therapy versus Metvix conventional Photodynamic Therapy in subjects with actinic keratosis [Estudio multicentrico, aleatorizado, enmascarado para el investigador, con control intraindividual con fármaco activo y con vehículo, de comparación entre el tratamiento fotodinámico Metvix con luz solar natural y el tratamiento fotodinamico Metvix convencional en pacientes con queratosis actínica]

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2015

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms COMET2
  • Sponsors Galderma
  • Most Recent Events

    • 11 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 26 Jul 2013 Planned end date changed from 1 Feb 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 15 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-000973-54).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top